Liver disease is a growing concern, often progressing silently until significant damage has occurred. Traditional diagnostic methods, while effective, can be invasive and carry inherent risks. Ramin Farboud MD is at the forefront of liver health assessment, offering FibroScan® – a revolutionary, non-invasive technology that provides rapid and accurate insights into liver stiffness and fat content. This advanced procedure empowers both patients and physicians with crucial information, enabling earlier diagnosis, more precise monitoring, and ultimately, better management of various liver conditions.
Understanding
Liver Stiffness and Fat
Liver stiffness, or fibrosis, is a key indicator of liver damage. It occurs when healthy liver tissue is replaced by scar tissue, impairing the liver's ability to function properly. As fibrosis progresses, it can lead to cirrhosis and even liver cancer. Similarly, excess fat accumulation in the liver, known as steatosis or fatty liver disease, can contribute to inflammation and damage. FibroScan® precisely measures both of these critical parameters, providing a comprehensive view of liver health without the need for a biopsy.
Your physician may recommend a FibroScan® test
if you have one of the following chronic liver conditions:
Autoimmune Hepatitis
Cirrhosis
Genetic Diseases
Hepatitis B & C
Alcoholic Liver Disease
Non-Alcoholic Steatohepatitis
Quick, Comfortable,
and Convenient
The FibroScan® procedure is remarkably quick and comfortable, typically taking only 5 to 10 minutes to complete. Patients simply lie on their back with their right arm raised above their head. A trained technician then applies a water-based gel to the skin over the liver and places the FibroScan® probe on the chest, gently pressing it against the skin. Most patients report feeling only a slight vibration or pressure during the examination, with no pain or discomfort. Its ease of use makes it suitable for frequent monitoring.
Empowering Patients and Physicians
By providing immediate, objective, and reproducible results, FibroScan® empowers both patients and physicians. Patients gain a clearer understanding of their liver health, which can motivate adherence to lifestyle changes and treatment plans. For physicians, FibroScan® data allows for more informed clinical decisions, personalized treatment strategies, and proactive management of liver disease, ultimately leading to improved patient outcomes and a reduction in the burden of advanced liver disease.